RVPH Dividend: Reviva Pharmaceuticals Holdings Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

RVPH Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	7	8	5	5	2
Research & Development	19	22	31	22	4	0
Operating Expenses	27	30	39	28	10	2
Other Non Operating Income (Expenses)	0	0	0	0	1	--
Pretax Income	-27	-29	-39	-28	-8	-3
Income Tax Expense	0	0	0	0	0	0
Net Income	-27	-29	-39	-28	-8	-3
Net Income Growth	-25%	-26%	39%	250%	167%	--
Shares Outstanding (Diluted)	49.84	33.14	23.79	19.51	14.79	3.06
Shares Change (YoY)	63%	39%	22%	32%	383%	17%
EPS (Diluted)	-0.54	-0.9	-1.65	-1.45	-0.58	-1.24
EPS Growth	-55%	-45%	14%	150%	-53%	-617%
Free Cash Flow	-26	-33	-28	-18	-10	-4
Free Cash Flow Per Share	-0.52	-0.99	-1.17	-0.92	-0.67	-1.3
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	-10	-2
EBITDA Margin	--	--	--	--	0%	0%
D&A For EBITDA	--	--	--	--	0	0
EBIT	-27	-30	-39	-28	-10	-2
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%